Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases

Molecular and Cellular Biochemistry

Volumn 230, Issue 1-2, 2002, Pages 31-47

  Tremblay, Johanne ^a   Desjardins, Richard ^a   Hum, David ^a   Gutkowska, Jolanta ^a   Hamet, Pavel ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cardiomyopathy; Genetics; Guanylyl cyclases; Hypertension; Natriuretic peptides

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; GUANOSINE TRIPHOSPHATE; GUANYLATE CYCLASE; LIGAND; MEMBRANE ENZYME; NATRIURETIC PEPTIDE TYPE C; PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOCHEMISTRY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME STRUCTURE; GENE SEGREGATION; HEART FUNCTION; HUMAN; KIDNEY FUNCTION; KNOCKOUT GENE; LIGAND BINDING; MOUSE; NONHUMAN; OLIGOMERIZATION; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BLOOD VOLUME; CARDIOMYOPATHIES; DOWN-REGULATION; GUANYLATE CYCLASE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; ISOENZYMES; NATRIURETIC PEPTIDE, BRAIN; RECEPTORS, PEPTIDE; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 0036196947     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014260204524     Document Type: Review

References (204)

1. Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3′,5′-monophosphate from guanosine triphosphate
2. Guanyl cyclase. Determination of enzyme activity
3. Kinetic analysis of sea urchin sperm guanylate cyclase
4. Evidence for two different forms of guanylate cyclase in rat heart
5. Characterization of particulate and soluble guanylate cyclases from rat lung
6. Receptor-mediated regulation of guanylate cyclase activity in spermatozoa
7. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
8. Effect of atrial natriuretic factor on metabolism of cGMP
9. Effect of native and synthetic atrial natriuretic factor on cyclic GMP
10. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues
11. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle
12. The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase
13. Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung
14. Coexistence of guanylate cyclase and atrial natriuretic factor receptor in a 180-kD protein
15. 1 receptor from bovine adrenal zona glomerulosa: Purification, characterization, and modulation by amiloride
16. ANF stimulation of detergent-dispersed particulate guanylate cyclase from bovine adrenal cortex
17. Guanylyl cyclase is a heat-stable enterotoxin receptor
18. Mice lacking the guanylyl cyclase C receptor are resistant to STa-induced intestinal secretion
19. A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons
20. A structural motif that defines the ATP-regulatory module of guanylate cyclase in atrial natriuretic factor signalling
21. Structural and biochemical identity of retinal rod outer segment membrane guanylate cyclase
22. Two membrane forms of guanylyl cyclase found in the eye
23. The cloning and expression of a new guanylyl cyclase orphan receptor
24. Guanylyl cyclases and signaling by cyclic GMP
25. Interaction of PDGF and natriuretic peptides on mesangial cell proliferation and endothelin secretion
26. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells
27. Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells
28. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts
29. A new natriuretic peptide in porcine brain
30. Isolation and identification of high molecular weight brain natriuretic peptide in porcine cardiac atrium
31. C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain
32. Cloning and sequence analysis of cDNA encoding a precursor for rat C-type natriuretic peptide (CNP)
33. Renal actions of synthetic dendroaspis natriuretic peptide
34. Structure and physiological actions of rat atrial natriuretic factor
35. Endogenous natriuretic peptides: Effect on collecting duct function in rat kidney
36. Purification and characterization of two types of atrial natriuretic factor receptors from bovine adrenal cortex: Guanylate cyclase-linked and cyclase-free receptors
37. Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction
38. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family
39. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases
40. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)
41. Physiological role of silent receptors of atrial natriuretic factor
42. Atrial natriuretic factor inhibits adenylate cyclase activity
43. Stimulatory effects of atrial natriuretic factor on phosphoinositide hydrolysis in cultured bovine aortic smooth muscle cells
44. A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function
45. The primary structure of the rat guanylyl cyclase A/atrial natriuretic peptide receptor gene
46. Sp 1 dependence of natriuretic peptide receptor A gene transcription in rat aortic smooth muscle cells
47. Functional interaction of NF-Y and Sp1 is required for type a natriuretic peptide receptor gene transcription
48. Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor
49. Ligand-dependent regulation of NPR-A gene expression in inner medullary collecting duct cells
50. Regulation of the atrial natriuretic peptide receptor by heat shock protein 90 complexes
51. The protein kinase domain of the ANP receptor is required for signaling
52. The relevance of N-linked glycosylation to the binding of a ligand to guanylate cyclase C
53. Human natriuretic peptide receptor-A guanylyl cyclase
54. Characterization of the functional domains of the natriuretic peptide receptor/guanylate cyclase by radiation inactivation
55. Bifunctional atrial natriuretic peptide receptor (type A) exists as a disulfide-linked tetramer in plasma membranes of bovine adrenal cortex
56. Ligand-independent oligomerization of natriuretic peptide receptors
57. Human natriuretic peptide receptor-A guanylyl cyclase is self-associated prior to hormone binding
58. Ligand binding-dependent limited proteolysis of the atrial natriuretic peptide receptor: Juxtamembrane hinge structure essential for transmembrane signal transduction
59. Identification and characterization of the phosphorylation sites of the guanylyl cyclase-linked natriuretic peptide receptors A and B
60. A constitutively 'phosphorylated' guanylyl cyclase-linked atrial natriuretic peptide receptor mutant is resistant to desensitization
61. Participation of adenosine 5′-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor
62. Structural requirements of ATP for activation of basal and atrial natriuretic factor-stimulated guanylate cyclase in rat lung membranes
63. Adenine nucleotide regulation of particulate guanylate cyclase from rat lung
64. Adenine nucleotides are required for activation of rat atrial natriuretic peptide receptor/guanylyl cyclase expressed in a baculovirus system
65. Allosteric modulation by ATP of the bovine adrenal natriuretic factor R1 receptor functions
66. The guanylyl cyclase-A receptor transduces an atrial natriuretic peptide/ATP activation signal in the absence of other proteins
67. Conservation of the kinase like regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases
68. Genetically tailored atrial natriuretic factor-dependent guanylate cyclase. Immunological and functional identity with 180 kDa membrane guanylate cyclase and ATP signaling site
69. Core sequence of ATP regulatory module in receptor guanylate cyclases
70. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains
71. Dominant negative mutations of the guanylyl cyclase-A receptor
72. Identification of sequences mediating guanylyl cyclase dimerization
73. ATP bimodal switch that regulates the ligand binding and signal transduction activities of the atrial natriuretic factor receptor guanylate cyclase
74. ATP modulation of the ligand binding and signal transduction activities of the type C natriuretic peptide receptor guanylate cyclase
75. Hormonal induction of low affinity receptor guanylyl cyclase
76. Stoichiometry of the atrial natriuretic factor-R1 receptor complex in the bovine zona glomerulosa
77. Dual regulation of atrial natriuretic factor-dependent guanylate cyclase activity by ATP
78. Cloning and expression of an ATP-regulated human retina C-type natriuretic factor receptor guanylate cyclase
79. Opposing adenine nucleotide-dependent pathways regulate guanylyl cyclase C in rat intestine
80. Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization
81. Protein kinase C-dependent desensitization of the atrial natriuretic peptide receptor is mediated by dephosphorylation
82. Proper glycosylation and phosphorylation of the type A natriuretic peptide receptor are required for hormone-stimulated guanylyl cyclase activity
83. Identification and characterization of the major phosphorylation sites of the B-type natriuretic peptide receptor
84. Phosphorylation of the kinase homology domain is essential for activation of the A-type natriuretic peptide receptor
85. Blood pressure and sodium intake
86. Involvement of the angiotensin II type 2 receptor in apoptosis during human fetal adrenal gland development
87. Regulation of guanylate cyclase activity by atrial natriuretic factor and protein kinase C
88. Targeting of a distinctive protein serine phosphatase to the protein kinase-like domain of the atrial natriuretic peptide receptor
89. Down-regulation of atrial natriuretic peptide receptor and cyclic GMP response in cultured rat vascular smooth muscle cells
90. Receptor binding, cGMP stimulation and receptor desensitization by atrial natriuretic peptides in cultured A10 vascular smooth muscle cells
91. Down-regulation of atrial natriuretic factor receptors and correlation with cGMP stimulation in rat cultured vascular smooth muscle cells
92. Regulation of the atrial natriuretic peptide receptor on a smooth muscle cell
93. Vascular atrial natriuretic factor receptor subtypes are not independently regulated by atrial peptides
94. Vascular receptors for atrial natriuretic peptide in spontaneously hypertensive rats
95. Kinetic analysis of internalization, recycling and redistribution of atrial natriuretic factor-receptor complex in cultured vascular smooth-muscle cells. Ligand-dependent receptor down-regulation
96. Regulation of atrial natriuretic peptide receptors in cultured vascular smooth muscle cells of rat
97. Differential internalization and processing of atrial-natriuretic-factor B and C receptor in PC12 cells
98. Functional domains and expression of truncated atrial natriuretic peptide receptor-A: The carboxyl-terminal regions direct the receptor internalization and sequestration in COS-7 cells
99. Vascular receptor binding activities and cyclic GMP responses by synthetic human and rat atrial natriuretic peptides (ANP) and receptor down-regulation by ANP
100. 1 in cultured aortic smooth muscle cells
101. Characterization and localization of a cGMP response element in the guanylyl cyclase A (GC-A) promoter
102. Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells
103. Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells: Role of cGMP
104. Downregulation of C-receptor by natriuretic peptides via ANP-B receptor in vascular smooth muscle cells
105. C-type natriuretic peptide: The endothelial component of the natriuretic peptide system
106. Role of atrial natriuretic factor in volume control
107. Effects of natriuretic peptide receptor inhibition on remnant kidney function in rats
108. Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist
109. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension
110. TGF-beta1-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man
111. Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation
112. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system
113. Physiologic role and diuretic efficacy of atrial natriuretic peptide in health and chronic renal disease
114. Effects of auriculin (ANF) on blood pressure, renal function, and the renin-aldosterone system in dogs
115. Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats
116. Effects of omapatrilat in low, normal, and high renin experimental hypertension
117. Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens
118. Regulation of adenosine cyclic 3′,5′-monophosphate and guanosine cyclic 3′,5′-monophosphate levels and contractility in bovine tracheal smooth muscle
119. Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical-activity of various tissues
120. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine
121. Effects of nitroprusside and 8-bromo-cyclic GMP on the contractile activity of the rat aorta
122. Cyclic GMP and mechanisms of vasodilation
123. Cyclic nucleotides and regulation of vascular smooth muscle
124. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells
125. Cyclic guanosine monophosphate as a mediator of vasodilation
126. 2+ levels in cultured vascular smooth muscle cells
127. Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation
128. Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells
129. Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts
130. Atrial natriuretic peptide elevation in congestive heart failure in the human
131. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
132. Cardiac fibrosis in mice lacking brain natriuretic peptide
133. Cosegregation analysis in genetic crosses suggests a protective role for atrial natriuretic factor against ventricular hypertrophy
134. Functional alterations of the Nppa promoter are linked to cardiac ventricular hypertrophy in WKY/WKHA rat crosses
135. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells
136. Natriuretic peptides inhibit G protein activation. Mediation through cross-talk between cyclic GMP-dependent protein kinase and regulators of G protein-signaling proteins
137. Cyclic-GMP-dependent protein kinase inhibits the Ras/Mitogen-activated protein kinase pathway
138. Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells
139. Angiotensin 1-converting enzyme activity and vascular sensitivity to angiotensin I in rat carotid artery
140. C-type natriuretic peptide inhibits intimal thickening after vascular injury
141. Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth
142. Adenovirus-mediated atrial natriuretic protein expression in the lung protects rats from hypoxia-induced pulmonary hypertension
143. Hypertension: Genes and environment
144. Clinical relationships of cyclic GMP
145. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension
146. Effect of natural and synthetic atrial natriuretic factor on arterial blood pressure, natriuresis and cyclic GMP excretion in spontaneously hypertensive rats
147. Cardiovascular, renal and endocrine responses to low doses of atrial natriuretic factor in mild essential hypertension
148. Effects of chronic excess salt ingestion - Evidence that genetic factors play an important role in susceptibility to experimental hypertension
149. Effects of chronic excess salt ingestion: Modification of experimental hypertension in rat by variations in the diet
150. Atrial natriuretic factor in Dahl rats - Atrial content and renal and aortic responses
151. Dahl S rats have increased natriuretic factor in atria but are markedly hyporesponsive to it
152. Atrial natriuretic factor in spontaneously hypertensive rats: Concentration changes with the progression of hypertension and elevated formation of cyclic GMP
153. Renal and blood pressure responses to synthetic atrial natriuretic factor in spontaneously hypertensive rats
154. Alteration of atrial natriuretic peptide binding sites in spontaneously hypertensive rats
155. Specific binding of atrial natriuretic polypeptide to renal basolateral membranes in spontaneously hypertensive rats (SHR) and stroke-prone SHR
156. Binding sites for atrial natriuretic factor (ANF) in kidneys and adrenal glands of spontaneously hypertensive (SHR) rats
157. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats
158. Congenic strains for the blood pressure quantitative trait locus on rat chromosome 2
159. Dissection of rat chromosome 2 with congenic strains support the ANP-receptor, GC-A as a candidate gene of hypertension in the Dahl rat
160. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide
161. The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: Acute handling of sodium and water in response to volume expansion
162. Atrial natriuretic peptide in heart failure
163. Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure
164. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure
165. Losartan improves the natriuretic response to ANF in rats with high-output heart failure
166. Regulation of renal glomerular and papillary ANP receptors in rats with experimental heart failure
167. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex
168. Decreased atrial natriuretic factor receptors and impaired cGMP generation in glomeruli from the cardiomyopathic hamster
169. Decreased atrial natriuretic peptide binding in renal medulla in rats with chronic heart failure
170. Glomerular and vascular atrial natriuretic factor receptors in cardiomyopathic hamsters: Correlation with the peptide biological effects
171. Attempts to alter the heterogeneous response to ANP in sodium-retaining caval dogs
172. Atrial natriuretic factor binding sites in experimental congestive heart failure
173. Glomerular atrial natriuretic factor receptors in experimental congestive heart failure
174. Divergent regulation of atrial natriuretic factor receptors in high-output heart failure
175. Atrial natriuretic peptide in relative polycythemia and polycythemia vera
176. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)
177. Identification of B-receptor for natriuretic peptide in human kidney
178. Regulation of renal atrial natriuretic peptide receptors in pregnant sheep
179. Renal atrial natriuretic factor receptors in hamster cardiomyopathy
180. Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure
181. Binding sites for atrial natriuretic peptide on platelets in patients with congestive cardiomyopathy
182. Renin and aldosterone in the cardiomyopathic hamster in congestive heart failure
183. Influence of heart failure and sodium content in the diet on the natriuretic response to furosemide in hamsters
184. Characterization, distribution, and plasticity of atrial natriuretic factor binding sites in brain
185. Maintenance of forearm vasodilator action of atrial natriuretic factor in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
186. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure
187. Baroreceptor function in congestive heart failure: Effect on neurohumoral activation and regional vascular resistance
188. Atrial natriuretic factor stimulation of particulate guanylate cyclase in the alveolar zone of hamster lung: A cytochemical study
189. Alteration of lung atrial natriuretic peptide receptors in genetic cardiomyopathy
190. Protective effect of alpha-human atrial natriuretic polypeptide (alpha-hANP) on chemical-induced pulmonary edema
191. Atrial natriuretic peptide regulation of endothelial permeability is mediated by cGMP
192. Role of atrial natriuretic factor in lung physiology and pathology
193. Clearance receptor-mediated control of atrial natriuretic factor in experimental congestive heart failure
194. Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor
195. Lung is an important source of atrial natriuretic factor in experimental cardiomyopathy
196. Gene expression of natriuretic peptide receptors in myocardial cells
197. 2+ in guinea pig cardiac myocytes
198. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat
199. Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats
200. Atrial natriuretic factor in normal subjects and heart failure patients-plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion
201. Abnormalities in systemic norepinephrine kinetics in human congestive heart failure
202. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure
203. Bay K 8644, a voltage-sensitive calcium channel agonist, facilitates secretion of atrial natriuretic polypeptide from isolated perfused rat hearts
204. Vasopeptidase inhibition: A new concept in blood pressure management